Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001104659-24-130954
Filing Date
2024-12-20
Accepted
2024-12-20 21:00:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4441
  Complete submission text file 0001104659-24-130954.txt   6123
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Reporting) CIK: 0001425738 (see all company filings)

EIN.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144

Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Subject) CIK: 0001434316 (see all company filings)

EIN.: 651311552 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36076 | Film No.: 241569501
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)